Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Advanced HR - Positive, HER2 - Negative Breast Cancer × palbociclib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Diseases 1 Advanced HR - Positive, HER2 - Negative Breast Cancer 1

Interventions

palbociclib 1 Sirolimus 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06856200 2025-03-04

A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

Fudan University

Phase NA Recruiting

Advanced HR - Positive, HER2 - Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡